Target intelligence / Profile preview

Dendritic cell (antigen-presenting cell) (DC)

Target
DC
Molecular classification
Other (specialized immune cell subtype), Antigen-presenting cell
01

Overview

Dendritic cells are specialized antigen-presenting cells critical for bridging innate and adaptive immunity. Upon encountering pathogens or danger signals, dendritic cells uptake, process, and present antigens on their surface (via MHC class I or II molecules) to T-cells, along with essential costimulatory signals (such as CD80, CD86, and CD40). This activation process is regulated by signaling pathways, including NF-κB and MAPK, and the resulting cytokine production directs the ensuing immune response, including T-cell priming, polarization, and effector functions. Dendritic cell activation is important for immunity to infections and tumors but must be tightly controlled to prevent autoimmunity or chronic inflammation[3][4][5][6][10].

Other names
Antigen-presenting cell (APC)Professional antigen-presenting cellDendritic antigen-presenting cell
02

Mechanism of action

Blockade of costimulatory molecule engagement (e.g., inhibition of CD80/CD86-CD28 interaction); Modulation of cytokine signaling; Inhibition of dendritic cell maturation/activation pathways[3][4]

03

Biological functions

Immune response activationAntigen presentationT-cell activationCytokine productionImmune tolerance regulation
04

Disease associations

CancerInfectionAutoimmune diseaseInflammation
05

Safety considerations

Overactivation may trigger autoimmunity or cytokine release syndromeSuppression may cause immunodeficiency or increased infection risk
06

Interacting drugs

CTLA-4-Ig (abatacept)

3 more in the full profile.

07

Biomarkers

Surface expression of CD80, CD86, CD40, MHC class I/II (to assess DC activation)Cytokine levels (e.g., IL-12, TNFα, IFN-α/β)

Beyond the preview

Go deeper on Dendritic cell (antigen-presenting cell) (DC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dendritic cell (antigen-presenting cell) (DC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call